 |
인쇄하기
취소
|
Anti-lung cancer drug, Iressa approved to sell.
The KFDA approved Iressa, an anti-lung cancer drug, originally developed by Astra-Zeneca in U.K. after the deliberation the Central Pharmaceutical Review Council on Mar. 20.
Iressa was first approved in Japan on July 5, 2002 and treated with more than 23,500 patients up to Jan. this year, showing, however, 173 cases of deaths due to its adverse reactions such as pneumonia. Accordingly, the K...
Iressa was first approved in Japan on July 5, 2002 and treated with more than 23,500 patients up to Jan. this year, showing, however, 173 cases of deaths due to its adverse reactions such as pneumonia. Accordingly, the K...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.